ViGenCell Inc. (KOSDAQ:308080)
South Korea
· Delayed Price · Currency is KRW 5,580.00
0.00 (0.00%)
At close: Mar 6, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 114.39 billion as of March 9, 2026. Its market cap has increased by 141.87% in one year.
Market Cap
114.39B
Enterprise Value
77.09B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,580.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 114.39B, a decrease of -79.62%. That is a compound annual growth rate of -29.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 114.39B | -42.77% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 117.37B |
| BIO-FD&C | 122.00B |
| IMGT Co.,Ltd. | 106.96B |
| CORESTEMCHEMON | 123.54B |
| Quratis | 103.62B |
| TegoScience | 103.44B |
| Progen | 100.55B |
| Cell Biotech | 96.29B |